CIBC Private Wealth Group
CLDX icon

CIBC Private Wealth Group’s Celldex Therapeutics CLDX Stock Holding History

CIBC Private Wealth Group’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$13.6K Hold
500
– – ﹤0.01% 2311
2025
Q3 		$12.9K Hold
500
– – ﹤0.01% 2296
2025
Q2 		$10.2K Hold
500
– – ﹤0.01% 2251
2025
Q1 		$7.57K Hold
500
– – ﹤0.01% 2325
2024
Q4 		$13.3K Hold
500
– – ﹤0.01% 2181
2024
Q3 		$17K Hold
500
– – ﹤0.01% 2228
2024
Q2 		$18.2K Hold
500
– – ﹤0.01% 2071
2024
Q1 		$20.8K Buy
+500
New +$20.5K ﹤0.01% 2028

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return